Details for New Drug Application (NDA): 050549
✉ Email this page to a colleague
NDA 050549 describes MEZLIN, which is a drug marketed by Bayer Pharms and is included in four NDAs. Additional details are available on the MEZLIN profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
Summary for 050549
| Tradename: | MEZLIN |
| Applicant: | Bayer Pharms |
| Ingredient: | mezlocillin sodium monohydrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050549
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
